Cancer clinical trials in the region Auvergne-Rhône-Alpes
445 currently recruiting clinical trials
Looking for clinical trials?
Clinical trial search is a complex process, with countless criteria to consider. Our AI assistant navigates this complexity with precise, expert-level analysis of the most relevant trials based on your medical profile. Our database is fully up to date, so you see only actively recruiting sites. It's fast and easy:
- Create your account
- Copy-paste your latest medical report
- Our AI-based assistant does the rest for you
Whether you are a patient or a doctor, create an account to find and apply for the most relevant clinical trials:
Phase 2
Pancreas cancer
#NCT05968326
#2022-502404-73-00
Adenocarcinoma
Localized
None
Systemic Treatment-Naive
Surgery
5 recruiting sites
Genentech, Inc
Phase 2
Breast cancer
#NCT06330064
#2023-509632-26-00
HER2 Negative
HR Positive
Locally Advanced
Metastatic
2
3 or more
Targeted therapy
Hormone therapy
Systemic Treatment-Naive
10 recruiting sites
Daiichi Sankyo
Phase 2
Breast cancer
#NCT06330064
#2023-509632-26-00
HER2 Low
HR Positive
Locally Advanced
Metastatic
2
3 or more
Targeted therapy
Hormone therapy
Systemic Treatment-Naive
10 recruiting sites
Daiichi Sankyo
Phase 2
Breast cancer
Lung cancer
Prostate cancer
Colon cancer
Rectal cancer
Kidney cancer
Pancreas cancer
Liver and bile duct cancer
Bladder / Urinary Tract / Urethral cancer
Stomach and esophageal cancer
Endometrial cancer
Ovarian / Fallopian tubes / Peritoneum cancer
#NCT04116541
#2023-510567-35-00
Locally Advanced
Metastatic
Metastatic Castration-resistant
Other mutation
1
2
3 or more
Systemic Treatment-Naive
8 recruiting sites
Centre Léon Bérard
Phase 2
Breast cancer
Lung cancer
Prostate cancer
Colon cancer
Rectal cancer
Kidney cancer
Pancreas cancer
Liver and bile duct cancer
Bladder / Urinary Tract / Urethral cancer
Stomach and esophageal cancer
Endometrial cancer
Ovarian / Fallopian tubes / Peritoneum cancer
#NCT04116541
#2023-510567-35-00
Locally Advanced
Metastatic
Metastatic Castration-resistant
BRAF
1
2
3 or more
Systemic Treatment-Naive
8 recruiting sites
Centre Léon Bérard
Phase 2
Breast cancer
Lung cancer
Prostate cancer
Colon cancer
Rectal cancer
Kidney cancer
Pancreas cancer
Liver and bile duct cancer
Bladder / Urinary Tract / Urethral cancer
Stomach and esophageal cancer
Endometrial cancer
Ovarian / Fallopian tubes / Peritoneum cancer
#NCT04116541
#2023-510567-35-00
Locally Advanced
Metastatic
Metastatic Castration-resistant
ALK
1
2
3 or more
Systemic Treatment-Naive
8 recruiting sites
Centre Léon Bérard
Phase 2
Breast cancer
Lung cancer
Prostate cancer
Colon cancer
Rectal cancer
Kidney cancer
Pancreas cancer
Liver and bile duct cancer
Bladder / Urinary Tract / Urethral cancer
Stomach and esophageal cancer
Endometrial cancer
#NCT04116541
#2023-510567-35-00
Locally Advanced
Metastatic
Metastatic Castration-resistant
EGFR
MET
NTRK-1/2/3
RET
ROS-1
Other mutation
1
2
3 or more
Systemic Treatment-Naive
8 recruiting sites
Centre Léon Bérard
Phase 2
Endometrial cancer
#NCT05640999
Endometrioid adenocarcinoma
Serous adenocarcinoma
Clear cell carcinoma
Dedifferentiated and undifferentiated endometrial ...
Carcinosarcoma
Other
Stage I
Stage II
Stage III
Localized
POLE
None
Systemic Treatment-Naive
Surgery
Chemotherapy
4 recruiting sites
Canadian Cancer Trials Group
Phase 2
Breast cancer
#NCT05800275
HER2 Positive
Metastatic
1
2
3 or more
10 recruiting sites
UNICANCER
Phase 2
Lung cancer
#NCT04614103
NSCLC (Non-Small Cell Lung Cancer)
Metastatic
1
2
Immunotherapy
Chemotherapy
Targeted therapy
ALK
EGFR
ROS-1
6 recruiting sites
Iovance Biotherapeutics